Biotechnology, Health services, specialised, Health, medical and pharmaceutical · 2 Employees
Overview
Employees
Access 8 Verified Employees Profiles for Hox TherapeuticsUnlock Free Contacts Now
About
HOX Therapeutics is developing new treatments for prostate cancer including a new class of drugs based on the inhibition of HOX transcription factors, development genes which are overexpressed in cancer. In a parallel programme HOX is working on novel inhibitors of the androgen receptors in those patients insensitive to current drugs for castration resistant prostate cancer.